Atzpodien, J <br/><br/>
Rapid deterioration in quality of life during interleukin-2- and alpha-interferon-based home therapy of renal cell carcinoma is associated with a good outcome.  [electronic resource] 

 -  British journal of cancer  Jul 2003 
 - 50-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjc.6600996  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents--adverse effects<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carcinoma, Renal Cell--drug therapy<br/>Female<br/>Health Status<br/>Humans<br/>Injections, Subcutaneous<br/>Interferon-alpha--adverse effects<br/>Interleukin-2--adverse effects<br/>Isotretinoin--administration & dosage<br/>Kidney Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Outpatients<br/>Prognosis<br/>Quality of Life<br/>Treatment Outcome